25 LLC’s Exelixis EXEL Stock Holding History

25 LLC’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25	Closed	-$484	–	199
2023 Q2	$484	Sell	25 -2	-7%	-$39	﹤0.01%	563
2023 Q1	$514	Buy	+27	New	+$470	﹤0.01%	362

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

25 LLC's EXEL Position: Q3 2023 in Review

25 LLC sold out of Exelixis (EXEL) in Q3 2023, closing a stake of 25 shares — an estimated $484 sold.

25 LLC first reported a position in EXEL in Q1 2023 and held it in 2 quarters. The position peaked at $514 in Q1 2023. 397 funds tracked by Wall St. Rank hold EXEL as of Q3 2023.

25 LLC reported no remaining Exelixis position as of Q3 2023 after selling out during the quarter.
25 LLC sold 25 Exelixis shares in Q3 2023, an estimated $484.
25 LLC first reported a position in Exelixis in Q1 2023 and held it in 2 quarters.
25 LLC's Exelixis position peaked at $514 in Q1 2023.
397 funds tracked by Wall St. Rank held Exelixis as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.